Paul Simms

Paul Simms

Paul Simms's picture
Paul Simms is Chairman of eyeforpharma.

Latest posts from Paul:

Access and Evidence, Medical, Multichannel, Patients and Medical, Clinical, Commercial

Into pharma's roaring twenties

Jan 14, 2020

A new decade is here. And despite the incredible science, pharma is...

Column

eyeforpharma Awards: Recognizing...

Dec 19, 2019

Celebrating winners makes genuine innovation visible, setting the bar higher...

Clinical

Clinical must think outside, and...

Nov 21, 2019

From site-in-a-box to virtual/siteless trials: which new model will...

Patients and Medical

An Impatient Truth

Nov 9, 2018

How patients taught me that pharma’s partnership efforts simply aren’t...

Commercial

Stop Releasing Your Data Into The...

Sep 12, 2018

You don't have to give your data away for free. In fact, it is in...

Commercial

Want To Emulate A Startup?...

Aug 28, 2018

eyeforpharma Chairman, Paul Simms, explains why pharma companies are failing to...

Commercial

The Return Of The KAM

Oct 16, 2017

After decades in the shadows, companies are looking again at the key account...

Patients and Medical

Pharma’s social contract: time...

Sep 6, 2017

One year on, Brent Saunders of Allergan suggests to Paul Simms the case for...

Commercial

Engaging Kids to Fight Malaria

Dec 1, 2016

An interview with the team behind the MOSKI KIT, a Sanofi tool against malaria.

Commercial

"Creating Ripples" with...

Sep 30, 2016

Søren Eik Skovlund is changing the conversation about diabetes patients’...

Pages